Study Comparing the Use of Remifentanil Versus Propofol for Performing Bronchial Fibroscopy

PHASE4CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

April 3, 2017

Study Completion Date

April 3, 2017

Conditions
Realisation of Bronchial Fibroscopy
Interventions
DRUG

1: Remifentanil

1: Remifentanil group The infusion of Remifentanil by TCI begins at distance from the introduction of fiberoptic. The effect site target is 4 ng / ml.- A titration in increments or decrements (respectively increase or decrease of 1 ng / ml effect site concentration) separated by 1 minute intervals until an OAAS score of 4 and respiratory frequency range between 10 and 20 cycles per minute.

DRUG

2: Propofol

2: Propofol group- The infusion of Propofol by TCI begins at distance from the introduction of fiberoptic. The effect site target is 2,5 ng / ml.- A titration in increments or decrements (respectively increase or decrease of 0.5 mg / ml concentration effect site) separated by 1 minute intervals until an OAAS score of 4 and included respiratory rate between 10 and 20 cycles per minute.

Trial Locations (1)

75010

Hôpital Saint-Louis - Anesthésie Réanimation, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT01872754 - Study Comparing the Use of Remifentanil Versus Propofol for Performing Bronchial Fibroscopy | Biotech Hunter | Biotech Hunter